212-681-1575

Clinical trial
In October, MesotheliomaHelp reported about the “impressive” results of a mesothelioma clinical trial for an immunotherapy drug known as CRS-207. Last week, researchers reported at the European Lung Cancer Conference in Geneva, Switzerland that the positive Phase 1b trial results ...
Continue Reading

Want Specific topic updates?

T Cell

The science behind understanding how mesothelioma cells continue to divide and spread despite being inundated with toxic treatments has confounded researchers for years. If cancer ...

Read Full Story

Want Specific topic updates?

Clinical trial

In 2014, doctors at the Memorial Sloan-Kettering Cancer Center began testing a Wilms Tumor-1 (WT1) vaccine to see if it delays or prevents malignant pleural mesothelioma from growi ...

Read Full Story

Want Specific topic updates?

Man-in-laboratory-300x187

For patients diagnosed with lung cancer or mesothelioma, chemotherapy is the most commonly prescribed treatment for managing symptoms and slowing the growth of the disease. But bot ...

Read Full Story

Want Specific topic updates?

Chemo-bag-199x300

Nanotechnology is in the news again with a report that a new technique can determine within eight hours whether chemotherapy is effective for a patient. For mesothelioma patients, ...

Read Full Story

Want Specific topic updates?

1 2 3 19

Simple Share Buttons